|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
THERAPEUTIC REVIEWS/HERBAL MEDICINE |
From the School of Pharmacy and Drug Development Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, PRC.
Danshen, the dried root of Salvia miltiorrhiza, has been widely used in China and, to a lesser extent, in Japan, the United States, and other European countries for the treatment of cardiovascular and cerebrovascular diseases. In China, the specific clinical use is angina pectoris, hyperlipidemia, and acute ischemic stroke. The current review covers its traditional uses, chemical constituents, pharmacological activities, pharmacokinetics, clinical applications, and potential herb-drug interactions based on information obtained in both the English and Chinese literature. Although numerous clinical trials have demonstrated that certain Danshen products in China are effective and safe for the treatment of cardiovascular diseases, most of these lack sufficient quality. Therefore, large randomized clinical trials and further scientific research to determine its mechanism of actions will be necessary to ensure the safety, effectiveness, and better understanding of its action.
Key Words: Danshen Salvia miltiorrhiza danshensu salvianolic acid B tanshinone IIA
Address for reprints: Zhong Zuo, School of Pharmacy, Chinese University of Hong Kong, Shatin, N.T. Hong Kong; e-mail: joanzuo{at}cuhk.edu.hk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J. Liu, J. Morton, M. Miedzyblocki, T. F. Lee, D. L. Bigam, T. F. Fok, C. Chen, S. K. Lee, S. T. Davidge, and P.-Y. Cheung Sodium tanshinone IIA sulfonate increased intestinal hemodynamics without systemic circulatory changes in healthy newborn piglets Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1217 - H1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Shin, H.-N. Kim, K. D. Shin, Y. J. Yoon, S.-J. Kim, D. C. Han, and B.-M. Kwon Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells Cancer Res., January 1, 2009; 69(1): 193 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Nizamutdinova, G. W. Lee, J. S. Lee, M. K. Cho, K. H. Son, S. J. Jeon, S. S. Kang, Y. S. Kim, J. H. Lee, H. G. Seo, et al. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules Carcinogenesis, October 1, 2008; 29(10): 1885 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wieser, M. Cohen, A. Gaeddert, J. Yu, C. Burks-Wicks, S. L. Berga, and R. N. Taylor Evolution of medical treatment for endometriosis: back to the roots? Hum. Reprod. Update, September 1, 2007; 13(5): 487 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kim, S.-N. Jung, K. H. Son, S. R. Kim, T. Y. Ha, M. G. Park, I. G. Jo, J. G. Park, W. Choe, S.-S. Kim, et al. Antidiabetes and Antiobesity Effect of Cryptotanshinone via Activation of AMP-Activated Protein Kinase Mol. Pharmacol., July 1, 2007; 72(1): 62 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Kim, F. A. Sanchez, R. G. Duran, T. Kanetaka, and W. N. Duran Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2131 - H2137. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |